Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Clinical Breast Cancer|March 27, 2012
Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trialWinston W Tan, Jacob B Allred, Muhammad Salim, et al.
Genes & Development|January 21, 2003
Genetics of dark skin in miceKaren R Fitch, Kelly A McGowan, Catherine D van Raamsdonk, et al.
American Journal of Clinical Oncology|October 9, 2007
Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044)Aminah Jatoi, James A Martenson, Nathan R Foster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG studyC X Ma, P Steen, K M Rowland, et al.
Cancer|December 18, 2008
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047ADomingo G Perez, Vera J Suman, Tom R Fitch, et al.
American Journal of Therapeutics|July 22, 2006
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trialSteven R Alberts, Paul J Novotny, Jeff A Sloan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2003
A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancerJames A Martenson, Antonio P G Vigliotti, Henry C Pitot, et al.
Cancer|March 11, 2003
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinomaAminah Jatoi, Neil Ellison, Patrick A Burch, et al.
International Journal of Radiation Oncology, Biology, Physics|May 30, 2006
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancerSteven E Schild, William L McGinnis, David Graham, et al.
Haematologica|March 1, 2006
Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-pointsAngela Dispenzieri, Morie A Gertz, Martha Q Lacy, et al.
Pageof 11